Gynecomastia risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 2: | Line 2: | ||
{{Gynecomastia}} | {{Gynecomastia}} | ||
{{CMG}}; {{AE}} {{DAMI}} | |||
==Overview== | ==Overview== | ||
Revision as of 16:29, 18 May 2017
|
Gynecomastia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gynecomastia risk factors On the Web |
|
American Roentgen Ray Society Images of Gynecomastia risk factors |
|
Risk calculators and risk factors for Gynecomastia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
Risk Factors
Risk factors
- The most potent risk factor in the development of gynecomastia is idiopathic often multifactorial.
Common Risk Factors
- Idiopathic
- Drugs (12765)
- Cirrhosis
- Starvation and Refeeding
- Male hypogonadism
- Testicular neoplasms
- Hyperthyroidism
- Chronic Kidney disease
- Tumors
Less Common Risk Factors
- Feminizing adrenal tumors
- Ectopic hCG
- Disorders of sex development
- Familial prepubertal gynecomastia
References
- ↑ Braunstein GD (1993). "Gynecomastia". N Engl J Med. 328 (7): 490–5. doi:10.1056/NEJM199302183280708. PMID 8421478.